Marc Hedrick
Vermogen: 163 420 $ op 31-05-2026
Vermogen: 163 420 $ op 31-05-2026
Marc H.
Hedrick was the founder of StemSource, Inc., founded in 2000, where the titles held included President, Chief Executive Officer & Director from 2001 to 2003.
Dr. Hedrick currently holds the positions of President, Chief Executive Officer & Director at Plus Therapeutics, Inc. since 2019.
Former jobs include President, Chief Executive Officer & Director at Cytori Therapeutics, Inc. (JP); Chief Scientific Officer & Medical Director at MacroPore Biosurgery, Inc. from 2002 to 2004; Co-Director at UCLA Anderson School of Management; Director at Cytori Ltd.; and Associate Professor at the University of California, Los Angeles.
Education includes a doctorate from The University of Texas Southwestern Medical Center conferred in 1988 and an MBA from UCLA Anderson School of Management conferred in 2005.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-05-2026 | 28.044 ( 0,41% ) | 163 216 $ | 31-05-2026 | |
| 25-07-2018 | 35 ( -.--% ) | 204 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Algemeen Directeur | 02-04-2014 |
| Bedrijven | Functie | Einde |
|---|---|---|
MacroPore Biosurgery, Inc. /Old/
MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Oprichter | 01-01-2003 |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
MacroPore Biosurgery, Inc. /Old/
MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Health Technology |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytori Ltd.
Cytori Ltd. Pharmaceuticals: OtherHealth Technology Develops biological products | Health Technology |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau